Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (10)

2022

  1. Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing

    Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153

2019

  1. Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.

    Stem Cell Research, Vol. 41

2016

  1. Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis

    Journal of Immunology, Vol. 197, Núm. 6, pp. 2145-2156

2008

  1. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys

    Movement Disorders, Vol. 23, Núm. 5, pp. 708-715

2006

  1. Glycine release in the substantia nigra: Interaction with glutamate and GABA

    Neuropharmacology, Vol. 50, Núm. 5, pp. 548-557

2003

  1. Firing regulation in dopaminergic cells: Effect of the partial degeneration of nigrostriatal system in surviving neurons

    European Journal of Neuroscience, Vol. 18, Núm. 1, pp. 53-60

  2. How is firing activity of substantia nigra cells regulated? Relevance of pattern-code in the basal ganglia

    Synapse, Vol. 49, Núm. 4, pp. 216-225

  3. Neuronal activity in the substantia nigra in the anaesthetized rat has fractal characteristics. Evidence for firing-code patterns in the basal ganglia

    Experimental Brain Research, Vol. 151, Núm. 2, pp. 167-172

2001

  1. Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: An animal model of Parkinson's disease

    Behavioural Brain Research, Vol. 122, Núm. 1, pp. 79-92

1997

  1. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

    Genes Chromosomes and Cancer, Vol. 18, Núm. 2, pp. 84-93